Anterogen.Co.Ltd KOSDAQ065660 shareholders incur further losses as stock declines 11 percent this week, taking three-year losses to 85 percent - Simply Wall St
| 065660 Stock | KRW 16,670 100.00 0.60% |
About 62% of AnterogenCoLtd's investor base is looking to short. The analysis of current outlook of investing in AnterogenCoLtd suggests that many traders are alarmed regarding AnterogenCoLtd's prospects. The current market sentiment, together with AnterogenCoLtd's historical and current headlines, can help investors time the market. In addition, many technical investors use AnterogenCoLtd stock news signals to limit their universe of possible portfolio assets.
AnterogenCoLtd |
Anterogen.Co.Ltd KOSDAQ065660 shareholders incur further losses as stock declines 11 percent this week, taking three-year losses to 85 Simply Wall St
Read at news.google.com
 |
AnterogenCoLtd Fundamental Analysis
We analyze AnterogenCoLtd's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AnterogenCoLtd using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AnterogenCoLtd based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Income
Net Income Comparative Analysis
AnterogenCoLtd is rated below average in net income category among its peers. Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
AnterogenCoLtd Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with AnterogenCoLtd stock to make a market-neutral strategy. Peer analysis of AnterogenCoLtd could also be used in its relative valuation, which is a method of valuing AnterogenCoLtd by comparing valuation metrics with similar companies.
Peers
AnterogenCoLtd Related Equities
| 330350 | Withuspharmaceutical | 5.77 | ||||
| 106190 | High Tech | 5.53 | ||||
| 102940 | Kolon Life | 5.06 | ||||
| 074430 | Aminologics CoLtd | 3.91 | ||||
| 047920 | HLB Pharmaceutical | 3.80 | ||||
| 009300 | Sam-A Pharm | 2.59 | ||||
| 072020 | Choong Ang | 2.11 | ||||
| 216080 | JETEMA Co | 0.36 | ||||
| 023910 | Daihan Pharmaceutical | 0.19 | ||||
| 065660 | AnterogenCoLtd | 0.60 |
Complementary Tools for AnterogenCoLtd Stock analysis
When running AnterogenCoLtd's price analysis, check to measure AnterogenCoLtd's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AnterogenCoLtd is operating at the current time. Most of AnterogenCoLtd's value examination focuses on studying past and present price action to predict the probability of AnterogenCoLtd's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AnterogenCoLtd's price. Additionally, you may evaluate how the addition of AnterogenCoLtd to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |